Logo
D

DelMar Pharmaceuticals

9 employees

Kintara Therapeutics is engaged in developing and commercializing therapies for the treatment of cancer patients.

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology
Medical
Health Care

Date founded

2010

Funding rounds raised

Total raised

$20M

from 3 investors over 3 rounds

D

DelMar Pharmaceuticals raised $2M on June 28, 2023

Investors: National Institutes of Health

D

DelMar Pharmaceuticals raised $20M on August 3, 2022

Investors: Lincoln Park Capital, LLC

D

DelMar Pharmaceuticals raised undisclosed on January 12, 2022

Investors: Fonds National de la Recherche

FAQ